Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1434 of 5804
-
Church-based diabetes program aims to curb soaring rates in marshall islands
Disease control Recruiting nowHealth disparities in the Republic of the Marshall Islands are striking, with extremely high rates of type 2 diabetes. Documented prevalence of type 2 diabetes in the Marshall Islands ranges from 20%-50%.This is significantly higher than the global (8.5%) and United States (11%) …
Phase: NA • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New radiation approach aims to ease head and neck cancer pain in fewer sessions
Symptom relief Recruiting nowTo learn if it is effective to use advanced radiation treatment techniques (stereotactic radiation or "SBRT") to safely deliver a strong dose of radiation to your tumor in a shorter period of time than would typically be feasible with traditional methods.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New combo therapy may slow severe nearsightedness in kids
Disease control CompletedPeripheral contact lens in controlling myopia progression in high myopia children(PAM)is a prospective, single-center, randomized controlled trial with three parallel arms conducted at Beijing Tongren Hospital. Chinese children aged 6-12 years with high myopia (spherical equivale…
Phase: PHASE4 • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Doulas and smart devices team up to tackle postpartum hypertension
Disease control OngoingThis is a single site, single-blinded parallel randomized control trial that investigates a multi-level intervention to improve postpartum blood pressure in women with hypertensive disorder pregnancy. The investigators will recruit women diagnosed with a hypertensive disorder of …
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Brain cancer breakthrough? CAR t cells injected directly into fluid around brain in new trial
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of intracerebroventricularly (ICV) administered CD19-chimeric antigen receptor (CAR) T cells in treating patients with central nervous system (CNS) lymphoma. CAR T cell therapy is a type of treatment in which a pati…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Soy supplement shows promise for aging brains and arteries
Disease control OngoingThe ACE Trial, funded by the National Institute on Ageing/National Institutes of Health (NIH), is a multicenter clinical trial. The ACE Trial will determine if taking the dietary supplement Equol could slow the progression of stiffening of the arteries, small blood vessel disease…
Phase: PHASE2 • Sponsor: Akira Sekikawa • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Laptop-based memory training may help reverse cognitive decline
Symptom relief Recruiting nowThe current study is a double-blind, placebo-control randomized clinical trial examining the efficacy of memory retraining in individuals with Mild Cognitive Impairment (MCI). Impairment in higher level cognitive processing, such as new learning and memory, is one of the most com…
Phase: NA • Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New lupus pill shows promise in Mid-Stage trial
Disease control CompletedA study evaluating the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GLPG3667 administered orally once daily for 48 weeks in approximately 180 adult participants with active Systemic Lupus Erythematosus (SLE).
Phase: PHASE2 • Sponsor: Lakefront Biotherapeutics NV • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
ER study aims to stop patients being awake and paralyzed on ventilators
Knowledge-focused Recruiting nowThe investigators will screen all mechanically ventilated ED patients for study eligibility and will enroll all consecutive patients satisfying inclusion and exclusion criteria. The study design is a pragmatic, multicenter, stepped wedge cluster randomized trial, enrolling at fi…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New hope for rare stomach cancer: chemo drug shows promise in early trial
Disease control Recruiting nowThe goal of this clinical trial is to investigate the efficacy and safety of temozolomide in SDH deficiency GIST patients.
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo therapy aims to cut pain and opioid use in chronic sufferers
Symptom relief OngoingThis is a prospective, randomized clinical trial of 204 patients with opioid use disorder (OUD) and chronic pain (CP) to test the effectiveness of treatment as usual compared with Stepped Care for Patients to Optimize Whole Recovery (SC-POWR) to reduce pain interference (Aim 1) a…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Smart algorithm aims to tailor blood thinner use after stents
Disease control Recruiting nowThe use of aspirin combined with a P2Y12 inhibitor (dual antiplatelet therapy, DAPT) represents the standard of care for patients undergoing percutaneous coronary intervention (PCI) with stent implantation. The TAILOR-DAPT trial aims to investigate the benefits of a score-based d…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 26, 2026 17:59 UTC
-
Experimental combo aims to boost immune attack on tough lung cancers
Disease control OngoingThis study is open to adults with small cell lung cancer and other neuroendocrine tumours that are positive for the tumour marker Delta-like 3 (DLL3). The study is in people with advanced cancer for whom previous treatment was not successful or no standard treatment exists. The …
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drip combo aims to stop chemo nausea in kids
Symptom relief CompletedChemotherapy-induced nausea and vomiting are serious side effects of cancer treatment that can have a significant negative impact on a patient's quality of life. Although the prevalence of nausea and vomiting has significantly decreased due to the implementation of new antiemetic…
Phase: PHASE3 • Sponsor: Immune Oncology Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New combo aims to tackle aggressive brain tumors that have come back
Disease control Recruiting nowGlioblastoma (GBM), WHO grade IV glioma, represents the majority of adult malignant primary brain tumors, with an incidence of 2-3 per 100,000 person-years. The survival for GBM has increased in the last decade but is still low with a median survival of 15-18 months. Recurrence a…
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Shockwave therapy opens hardened arteries for Life-Saving aortic repair
Disease control Recruiting nowThe study will evaluate, in a controlled setting, the efficacy and safety of the intravascular lithotripsy using Shockwave™ M5+/L6 Peripheral Intravascular Lithotripsy Catheter to facilitate delivery of aortic large-bore devices in iliac calcified access.
Sponsor: EndoCore Lab s.r.l. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New shot Mim8 shows promise for hemophilia a bleed control
Disease control CompletedThis study is looking at how safe it is to switch from emicizumab to Mim8, in people with haemophilia A. Mim8 is a new medicine that is used to prevent bleeding episodes in people with haemophilia A. Mim8 works by replacing the function of the missing clotting factor VIII (FVIII)…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New program aims to boost HIV care and safety for black women facing abuse
Disease control Recruiting nowThis study tests a 5-session cognitive behavioral approach program (herein referred to as the 1MoreStep intervention) to train Black women living with HIV (BWLWHI) and exposed to intimate partner violence (IPV) in the past 2 years (hereafter, BWLWHI) in: 1) cognitive and behavior…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New pacing technique could boost heart function in mild failure
Disease control OngoingThis is a two-center, prospective randomized controlled trial. The aim of this study is to compare the clinical efficacy of early left bundle branch pacing for cardiac resynchronization therapy and guideline-directed medical therapy in heart failure with mild-reduced ejection fra…
Phase: NA • Sponsor: Fu Wai Hospital, Beijing, China • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Real-World test: can a targeted drug keep PNH in check for years?
Disease control Recruiting nowThis is a 36-month, long-term, multicenter, observational study designed to describe the real world effectiveness of pegcetacoplan in patients with PNH. Patients meeting the eligibility criteria will be enrolled in the study and followed prospectively for approximately 36 months.…
Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC